Draft genome sequence of broad-spectrum antibiotic sparsomycin-producing Streptomyces sparsogenes ATCC 25498 from the American Type Culture Collection.
Sparsomycin, which exhibits rare broad-spectrum antibiotic and antitumour activity against bacteria, Archaea, Eucarya and various cancer cell lines, has been widely used as a powerful tool to study protein synthesis. Here we report the draft genome sequence of Streptomyces sparsogenes ATCC 25498 from the American Type Culture Collection (ATCC), which has become an organism of interest owing to its ability to produce sparsomycin. The whole-genome sequence of S. sparsogenes ATCC 25498 was determined using a high-throughput Illumina HiSeq 2000 platform and genome assembly was performed using the SOAPdenovo method. Whole-genome sequencing analysis revealed a genome size of 10.0Mb. A total of 41 secondary metabolite biosynthetic gene clusters were identified. The gene cluster for the biosynthesis of sparsomycin was localised on scaffold 9. The genome sequence of S. sparsogenes ATCC 25498 will not only aid in understanding the regulatory mechanism of sparsomycin biosynthesis but will also reveal the ability of the isolate to produce novel bioactive secondary metabolites.